Literature DB >> 27045771

Measurements of Monoclonal Antibody Self-Association Are Correlated with Complex Biophysical Properties.

Steven B Geng1, Michael Wittekind2, Adam Vigil2, Peter M Tessier1.   

Abstract

Successful development of monoclonal antibodies (mAbs) for therapeutic applications requires identification of mAbs with favorable biophysical properties (high solubility and low viscosity) in addition to potent bioactivities. Nevertheless, mAbs can also display complex, nonconventional biophysical properties that impede their development such as formation of soluble aggregates and subvisible particles as well as nonspecific interactions with various types of surfaces such as nonadsorptive chromatography columns. Here we have investigated the potential of using antibody self-interaction measurements obtained via affinity-capture self-interaction nanoparticle spectroscopy (AC-SINS) at dilute concentrations (0.01 mg/mL) for ranking a panel of 12 mAbs in terms of their expected biophysical properties at higher concentrations (1-30 mg/mL). Several mAb properties (solubility, % monomer, size-exclusion elution time and % recovery) displayed modest correlation with each other, as some mAbs with deficiencies in one or more properties (e.g., solubility) failed to show deficiencies in other properties (e.g., % monomer). The ranking of mAbs in terms of their level of self-association was correlated with their solubility ranking. However, the correlation was even stronger between the average ranking of the four biophysical properties and the AC-SINS measurements. This finding suggests that weak self-interactions detected via AC-SINS can manifest themselves in different ways and lead to complex biophysical properties. Our findings highlight the potential for using high-throughput self-interaction measurements to improve the identification of mAbs that possess a collection of excellent biophysical properties without the need for cumbersome analysis of each individual property during early candidate selection.

Keywords:  aggregation; mAb; self-association; size-exclusion chromatography; solubility; viscosity

Mesh:

Substances:

Year:  2016        PMID: 27045771     DOI: 10.1021/acs.molpharmaceut.6b00071

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  13 in total

1.  In vitro and in silico assessment of the developability of a designed monoclonal antibody library.

Authors:  Adriana-Michelle Wolf Pérez; Pietro Sormanni; Jonathan Sonne Andersen; Laila Ismail Sakhnini; Ileana Rodriguez-Leon; Jais Rose Bjelke; Annette Juhl Gajhede; Leonardo De Maria; Daniel E Otzen; Michele Vendruscolo; Nikolai Lorenzen
Journal:  MAbs       Date:  2019-01-18       Impact factor: 5.857

2.  Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokinetics.

Authors:  Lindsay B Avery; Jason Wade; Mengmeng Wang; Amy Tam; Amy King; Nicole Piche-Nicholas; Mania S Kavosi; Steve Penn; David Cirelli; Jeffrey C Kurz; Minlei Zhang; Orla Cunningham; Rhys Jones; Brian J Fennell; Barry McDonnell; Paul Sakorafas; James Apgar; William J Finlay; Laura Lin; Laird Bloom; Denise M O'Hara
Journal:  MAbs       Date:  2018-01-29       Impact factor: 5.857

3.  Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development.

Authors:  Martin Domnowski; Jan Jaehrling; Wolfgang Frieß
Journal:  Pharm Res       Date:  2020-01-08       Impact factor: 4.200

Review 4.  Selecting and engineering monoclonal antibodies with drug-like specificity.

Authors:  Charles G Starr; Peter M Tessier
Journal:  Curr Opin Biotechnol       Date:  2019-02-26       Impact factor: 9.740

5.  Development of a high-throughput solubility screening assay for use in antibody discovery.

Authors:  Qing Chai; James Shih; Caroline Weldon; Samantha Phan; Bryan E Jones
Journal:  MAbs       Date:  2019-03-26       Impact factor: 5.857

6.  High-throughput profiling of antibody self-association in multiple formulation conditions by PEG stabilized self-interaction nanoparticle spectroscopy.

Authors:  Samantha Phan; Auralee Walmer; Eudean W Shaw; Qing Chai
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

7.  Assessment of Therapeutic Antibody Developability by Combinations of In Vitro and In Silico Methods.

Authors:  Adriana-Michelle Wolf Pérez; Nikolai Lorenzen; Michele Vendruscolo; Pietro Sormanni
Journal:  Methods Mol Biol       Date:  2022

8.  Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies.

Authors:  Cholpon Tilegenova; Saeed Izadi; Jianping Yin; Christine S Huang; Jiansheng Wu; Diego Ellerman; Sarah G Hymowitz; Benjamin Walters; Cleo Salisbury; Paul J Carter
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

9.  QSAR Implementation for HIC Retention Time Prediction of mAbs Using Fab Structure: A Comparison between Structural Representations.

Authors:  Micael Karlberg; João Victor de Souza; Lanyu Fan; Arathi Kizhedath; Agnieszka K Bronowska; Jarka Glassey
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

10.  An accelerated surface-mediated stress assay of antibody instability for developability studies.

Authors:  Marie R G Kopp; Adriana-Michelle Wolf Pérez; Marta Virginia Zucca; Umberto Capasso Palmiero; Brigitte Friedrichsen; Nikolai Lorenzen; Paolo Arosio
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.